Iacovoni, A., DeMaria, R., Gavazzi, A., Grosu, A., Fontana, A., Guideri, S., et al. (2013). Natriuretic peptides and the Framingham Risk score for screening of asymptomatic left ventricular systolic dysfunction in high-risk patients in primary care. The DAVID-BERG study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 168(5), 5093-5095 [10.1016/j.ijcard.2013.07.260].

Natriuretic peptides and the Framingham Risk score for screening of asymptomatic left ventricular systolic dysfunction in high-risk patients in primary care. The DAVID-BERG study

Senni M
2013

Lettera in rivista
Scientifica
Asymptomatic left ventricular systolic dysfunction; Cardiovascular risk; Heart failure; Natriuretic peptide; Primary care; Screening;
English
Iacovoni, A., DeMaria, R., Gavazzi, A., Grosu, A., Fontana, A., Guideri, S., et al. (2013). Natriuretic peptides and the Framingham Risk score for screening of asymptomatic left ventricular systolic dysfunction in high-risk patients in primary care. The DAVID-BERG study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 168(5), 5093-5095 [10.1016/j.ijcard.2013.07.260].
Iacovoni, A; Demaria, R; Gavazzi, A; Grosu, A; Fontana, A; Guideri, S; Gori, M; Ferrari, P; Filippi, A; Rutili, M; Donzelli, L; Parolini, M; Senni, M
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10281/372060
Citazioni
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
Social impact